BioSpace News Archive

Millar, Inc., a medical device manufacturer and OEM solutions partner, is pleased to announce that they have received approval from the Therapeutic Goods Administration (TGA) in Australia for their Mikro-Cath™ Pressure Catheter.

AGAE Technologies, LLC, a specialty chemical and biotech company based in Corvallis, Oregon, is proud to announce that it is successfully operating the first fermentation and mass purification pilot plants in North America dedicated to producing naturally occurring rhamnolipid biosurfactants.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Epilepsy is a chronic neurological disorder that can cause unfounded and ongoing seizures.

Wilmington, Delaware, United States, Transparency Market Research Inc. – An emergency aid or treatment given to an individual who is injured or affected with a sudden illness, before the arrival of regular medical services can be termed as first aid.

Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company, announced its results for the first half-year ended June 30, 2022.

Amsterdam, the Netherlands - Royal Philips, a global leader in health technology, announced that Roy Jakobs is proposed to succeed Frans van Houten as President and Chief Executive Officer, effective October 15, 2022.

AlzeCure Pharma AB announced that Drug Discovery Today has published a new review article on the biological mechanism underlying AlzeCure’s NeuroRestore platform and its leading drug candidate ACD856.

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today reports its financial results for the second quarter ended June 30, 2022 and provides a corporate update.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference.

Simcha Therapeutics today announced the appointment of Sanuj Ravindran, M.D., as chief executive officer and director, and Jake Bauer as an independent member and chair of its board of directors.